Evidence map›Paper›PMID 32194361›Full record

ArticleEXCLI journal2020

RNA-protein correlation of liver toxicity markers in HepaRG cells.

Albert Braeuning, Almut Mentz, Felix F Schmidt, Stefan P Albaum, Hannes Planatscher, Jörn Kalinowski, Thomas O Joos, Oliver Poetz, Dajana Lichtenstein

Open access · greenAbstract read
In one paragraph

Article in EXCLI journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. BiombalanceAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Albert BraeuningGerman Federal Institute for Risk Assessment, Dept. Food Safety, Berlin, Germany.
Almut MentzCenter for Biotechnology (CeBiTec), Universität Bielefeld, Bielefeld, Germany.
Felix F SchmidtSignatope GmbH, Reutlingen, Germany.
Stefan P AlbaumCenter for Biotechnology (CeBiTec), Universität Bielefeld, Bielefeld, Germany.
Hannes PlanatscherSignatope GmbH, Reutlingen, Germany.
Jörn KalinowskiCenter for Biotechnology (CeBiTec), Universität Bielefeld, Bielefeld, Germany.
Thomas O JoosNMI Natural and Medical Sciences Institute at the University of Tübingen, Tübingen,Germany.
Oliver PoetzNMI Natural and Medical Sciences Institute at the University of Tübingen, Tübingen,Germany.
Dajana LichtensteinGerman Federal Institute for Risk Assessment, Dept. Food Safety, Berlin, Germany.
Signatope GmbH (Germany)Bielefeld University · DEFederal Institute for Risk Assessment · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The liver is a main target organ for the toxicity of many different compounds. While in general,

Indexed as

hepatocytesin vitro testingliver toxicityomicsrelative potency factors

Identifiers

PMID32194361
PMCPMC7068204
OpenAlexW3013990292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.